FDA Adverse Event Malfunction Summary report: N

RAPIDPOINT 500E BLOOD GAS SYSTEM

MDR report key: 21125106 · Received January 10, 2025

Report

Report Number
3002637618-2025-00004
Event Type
Malfunction
Date Received
January 10, 2025
Date of Event
December 9, 2024
Report Date
February 5, 2025
Manufacturer
SIEMENS HEALTHCARE DIAGNOSTICS, INC., POC HQ
Product Code
CHL
PMA / PMN Number
K192240
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
HR
Reporter Occupation
NURSE
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

THE CUSTOMER HAS PROVIDED INSTRUMENT FILES FOR FURTHER INVESTIGATION. INVESTIGATION IS UNDERWAY. THE CUSTOMER HAS RUN CALIBRATIONS AND QC AND THE INSTRUMENT IS OPERATIONAL. THE CAUSE OF THIS EVENT IS UNKNOWN.

Additional Manufacturer Narrative · 0

A REVIEW OF THE PROVIDED INSTRUMENT FILES FOR POTASSIUM (K+) INDICATES THAT THE INSTRUMENT WAS PERFORMING AS INTENDED FOR THE DURATION OF THE MEASUREMENT CARTRIDGE USE-LIFE. NO K+ SENSOR ERROR FLAGS WERE OBSERVED, CALIBRATION AND RAW SAMPLE RESPONSE PROFILES APPEARED TYPICAL, AND ALL AQC SAMPLES RECOVERED WITHIN THE PUBLISHED LIMITS. THE K+ SENSOR WAS PERFORMING AS INTENDED AT TIME OF ANALYSIS OF THE ESCALATED SAMPLE. DIFFERENCE IN MATRICES (WHOLE BLOOD VS SERUM) MAY HAVE IMPACTED THE DISCREPANT RESULTS. A DEFINITIVE ROOT CAUSE OF THIS ISSUE CANNOT BE DETERMINED. THE INSTRUMENT IS CURRENTLY INSTALLED AND PERFORMING AS INTENDED AT THE CUSTOMER SITE. THE INSTRUMENT REMAINED OPERATIONAL WITHOUT CHANGING THE MEASUREMENT CARTRIDGE. THE CAUSE OF THIS EVENT IS UNKNOWN. NO PRODUCT PROBLEM IDENTIFIED.

Description of Event or Problem · 0

THE CUSTOMER REPORTED THAT THEY RECEIVED A DISCREPANT HIGH POTASSIUM (K+) RESULT ON ONE PATIENT COMPARED TO RETESTING OF A NEW SAMPLE ON THEIR LABORATORY INSTRUMENT. THERE IS NO REPORT OF INJURY DUE TO THIS EVENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
657724 RAPIDPOINT 500E BLOOD GAS SYSTEM RP 500E CHL SIEMENS HEALTHCARE DIAGNOSTICS, INC., POC HQ

Patients

Seq Age Sex Outcome Treatment
1 61 YR Male